| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |